Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY.
Leukemia. 2023 Feb;37(2):339-347. doi: 10.1038/s41375-022-01802-y. Epub 2022 Dec 24.
Leukemia. 2023.
PMID: 36566271
Free PMC article.
Imatinib therapy of chronic myeloid leukemia restores the expression levels of key genes for DNA damage and cell-cycle progression.
Benito R, Lumbreras E, Abáigar M, Gutiérrez NC, Delgado M, Robledo C, García JL, Rodríguez-Vicente AE, Cañizo MC, Rivas JM.
Benito R, et al.
Pharmacogenet Genomics. 2012 May;22(5):381-8. doi: 10.1097/FPC.0b013e328351f3e9.
Pharmacogenet Genomics. 2012.
PMID: 22388797
Item in Clipboard
Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY.
Mansouri L, Thorvaldsdottir B, Sutton LA, Karakatsoulis G, Meggendorfer M, Parker H, Nadeu F, Brieghel C, Laidou S, Moia R, Rossi D, Catherwood M, Kotaskova J, Delgado J, Rodríguez-Vicente AE, Benito R, Rigolin GM, Bonfiglio S, Scarfo L, Mattsson M, Davis Z, Gogia A, Rani L, Baliakas P, Foroughi-Asl H, Jylhä C, Skaftason A, Rapado I, Miras F, Martinez-Lopez J, de la Serna J, Rivas JMH, Thornton P, Larráyoz MJ, Calasanz MJ, Fésüs V, Mátrai Z, Bödör C, Smedby KE, Espinet B, Puiggros A, Gupta R, Bullinger L, Bosch F, Tazón-Vega B, Baran-Marszak F, Oscier D, Nguyen-Khac F, Zenz T, Terol MJ, Cuneo A, Hernández-Sánchez M, Pospisilova S, Mills K, Gaidano G, Niemann CU, Campo E, Strefford JC, Ghia P, Stamatopoulos K, Rosenquist R.
Mansouri L, et al. Among authors: rivas jmh.
Leukemia. 2023 Feb;37(2):504. doi: 10.1038/s41375-023-01813-3.
Leukemia. 2023.
PMID: 36635392
Free PMC article.
No abstract available.
Item in Clipboard
Clinical, biological, and prognostic implications of SF3B1 co-occurrence mutations in very low/low- and intermediate-risk MDS patients.
Janusz K, Izquierdo MM, Cadenas FL, Ramos F, Sánchez JMH, Lumbreras E, Robledo C, Del Real JS, Caballero JC, Collado R, Bernal T, Pedro C, Insunza A, de Paz R, Xicoy B, Salido E, García JS, Mínguez SS, García CM, Muñoz AMS, Barba MS, Rivas JMH, Abáigar M, Campelo MD.
Janusz K, et al. Among authors: rivas jmh.
Ann Hematol. 2021 Aug;100(8):1995-2004. doi: 10.1007/s00277-020-04360-4. Epub 2021 Jan 6.
Ann Hematol. 2021.
PMID: 33409621
Item in Clipboard
Continuous oral cytarabine ocfosfate with interferon-alpha-2b for patients with newly diagnosed chronic myeloid leukaemia: a pilot study.
del Cañizo MC, Fisac MP, Galende J, Hurtado JA, Moro MJ, Rodriguez JA, Rivas JM, Tabernero MD; Castellano-Leonés Group on CML.
del Cañizo MC, et al.
Br J Haematol. 2001 Dec;115(3):541-4. doi: 10.1046/j.1365-2141.2001.03141.x.
Br J Haematol. 2001.
PMID: 11736933
Free article.
Item in Clipboard
Cite
Cite